Domenico Giuseppe DAscola
Overview
Explore the profile of Domenico Giuseppe DAscola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pepe A, Meloni A, Filosa A, Pistoia L, Borsellino Z, DAscola D, et al.
JACC Cardiovasc Imaging
. 2020 Feb;
13(5):1284-1286.
PMID: 32061556
No abstract available.
2.
Vitrano A, Ruffo G, Pepe A, DAscola D, Caruso V, Filosa A, et al.
Br J Haematol
. 2019 Jul;
186(6):e209-e211.
PMID: 31344255
No abstract available.
3.
Pistoia L, Meloni A, Salvadori S, Spasiano A, Lisi R, Rosso R, et al.
Blood Cells Mol Dis
. 2019 Mar;
77:1-7.
PMID: 30878912
Beta thalassemia major (β-TM) displays a great deal of phenotypic heterogeneity, not fully investigated in terms of cause-effect. We aimed to detect if different genotypic groups could be related to...
4.
Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, et al.
Eur Heart J Cardiovasc Imaging
. 2017 Feb;
19(3):299-309.
PMID: 28200076
Aims: Cardiovascular magnetic resonance (CMR) has dramatically changed the clinical practice in thalassemia major (TM), lowering cardiac complications. We prospectively reassessed the predictive value of CMR parameters for heart failure...
5.
Pepe A, Rossi G, Bentley A, Putti M, Frizziero L, DAscola D, et al.
Clin Drug Investig
. 2017 Feb;
37(5):453-464.
PMID: 28185140
Purpose: Deferiprone (DFP), deferasirox (DFX) and deferoxamine (DFO) are used in thalassaemia major (TM) patients to treat chronic iron overload. We evaluated the cost-effectiveness of DFP, compared with DFX and...
6.
Ferro E, Visalli G, La Rosa M, Civa R, Randazzo Papa G, DAscola D, et al.
Hematology
. 2016 Nov;
22(3):183-191.
PMID: 27801288
Objectives: Redox imbalance and genotoxic damage are commonly observed in β thalassaemic patients. The aim of this study was to assess the role of anaemia in oxidative and genotoxic damage...
7.
Fragomeno C, Roccabruna E, DAscola D
Blood Cells Mol Dis
. 2015 Oct;
55(4):382-6.
PMID: 26460263
Background: Patients with haematopoietic disorders requiring long-term blood transfusions are at risk of iron overload. This study aimed to investigate the efficacy and safety of long-term deferasirox monotherapy in patients...
8.
Fedele R, Cuzzola M, Irrera G, Pontari A, DAscola D, Oliva E, et al.
Leuk Lymphoma
. 2015 Aug;
57(4):969-72.
PMID: 26308385
No abstract available.
9.
Casale M, Meloni A, Filosa A, Cuccia L, Caruso V, Palazzi G, et al.
Circ Cardiovasc Imaging
. 2015 Aug;
8(8):e003230.
PMID: 26253625
Background: Cardiovascular magnetic resonance (CMR) plays a key role in the management of thalassemia major patients, but few data are available in pediatric population. This study aims at a retrospective...
10.
Ricchi P, Meloni A, Spasiano A, Neri M, Gamberini M, Cuccia L, et al.
Am J Hematol
. 2015 Aug;
90(11):1008-12.
PMID: 26228763
The aim of this study was to evaluate, in a large cohort of chronically transfused patients, whether the presence of extramedullary hematopoiesis (EMH) accounts for the typical patterns of cardiac...